One in four psychiatric patients in Denmark are readmitted and that carries major personal and societal costs. But can we predict who will be readmitted, while others return to everyday life without symptoms? That is exactly what Professor Kamilla Miskowiak aims to support through her latest research. The paper is published in the journal Neuropsychopharmacology.
Continue Reading this article here
